Page last updated: 2024-09-05

phosphatidylcholines and Coronary Restenosis

phosphatidylcholines has been researched along with Coronary Restenosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Azarbal, B; Bisgaier, CL; Cercek, B; Chyu, KY; Johansson, J; Kaul, S; Mirocha, J; Rukshin, V; Santos, R; Shah, PK; Tsang, VT	1

Other Studies

1 other study(ies) available for phosphatidylcholines and Coronary Restenosis

Article	Year
Intramural delivery of recombinant apolipoprotein A-IMilano/phospholipid complex (ETC-216) inhibits in-stent stenosis in porcine coronary arteries. Circulation, 2003, May-27, Volume: 107, Issue:20 Topics: Animals; Apolipoprotein A-I; Coronary Restenosis; Coronary Vessels; Disease Models, Animal; Injections, Intra-Arterial; Macromolecular Substances; Phosphatidylcholines; Phospholipids; Recombinant Proteins; Stents; Swine; Treatment Outcome; Vascular Patency	2003

Article

Year

Intramural delivery of recombinant apolipoprotein A-IMilano/phospholipid complex (ETC-216) inhibits in-stent stenosis in porcine coronary arteries.

Circulation, 2003, May-27, Volume: 107, Issue:20

Topics: Animals; Apolipoprotein A-I; Coronary Restenosis; Coronary Vessels; Disease Models, Animal; Injections, Intra-Arterial; Macromolecular Substances; Phosphatidylcholines; Phospholipids; Recombinant Proteins; Stents; Swine; Treatment Outcome; Vascular Patency

2003